Lemay JF, et al. - Researchers compared the clinical characteristics, diabetes management and metabolic control in youth with type 1 diabetes (T1D) and autism spectrum disorder (ASD)(T1D-ASD) with youth without ASD (T1D-non ASD). Despite their comorbidity, a similar metabolic control in the T1D-ASD group was seen compared to T1D-non ASD. In T1D treatment, awareness of ASD remained important as both conditions required long-term multi-disciplinary medical follow-up for optimal outcomes. For severe hypoglycemia, diabetic ketoacidosis, insulin doses, insulin pump therapy, and body mass index, unadjusted comparisons demonstrated no difference.